Bharat Parenterals Limited

BSE:541096 Stock Report

Market Cap: ₹9.0b

Bharat Parenterals Past Earnings Performance

Past criteria checks 0/6

Bharat Parenterals's earnings have been declining at an average annual rate of -13.9%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 3.5% per year.

Key information

-13.9%

Earnings growth rate

-6.0%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate3.5%
Return on equity-8.3%
Net Margin-0.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bharat Parenterals makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:541096 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,938-283420
30 Jun 242,820832950
31 Mar 242,5941452450
31 Dec 232,4182522150
30 Sep 232,4102432070
30 Jun 232,6182281940
31 Mar 232,1931571880
31 Dec 222,1961801690
30 Sep 221,9911651620
30 Jun 221,7731451510
31 Mar 222,1232131590
31 Dec 212,0291891620
30 Sep 212,1402301590
30 Jun 212,1062151470
31 Mar 212,0722041540
31 Dec 202,2342561550
30 Sep 202,4792831600
30 Jun 202,3352601560
31 Mar 202,3282411650
31 Dec 192,2092221560
30 Sep 192,3642071530
30 Jun 192,3202081500
31 Mar 192,2492121600
31 Dec 182,1861671710
30 Sep 181,6131341590
30 Jun 181,4661171440
31 Mar 181,376911320
31 Dec 171,2961001220
30 Sep 171,244851250
30 Jun 171,148801260
31 Mar 171,114691180
31 Dec 161,172741140
30 Sep 161,147711060
30 Jun 161,171661030
31 Mar 161,197651010
31 Mar 151,18774800
31 Mar 141,13765790

Quality Earnings: 541096 is currently unprofitable.

Growing Profit Margin: 541096 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 541096 is unprofitable, and losses have increased over the past 5 years at a rate of 13.9% per year.

Accelerating Growth: Unable to compare 541096's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 541096 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.5%).

Return on Equity

High ROE: 541096 has a negative Return on Equity (-8.32%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 23:42
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bharat Parenterals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution